Alexandria Real Estate Equities
ARE
#2319
Rank
S$10.18 B
Marketcap
S$58.94
Share price
-2.38%
Change (1 day)
-56.29%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -S$19.21 Million

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are S$2.97 Billion. In 2024 the company made an earning of S$0.90 Billion, an increase over its 2023 earnings that were of S$0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$19.21 Million-102.13%
2024 S$0.90 B96.11%
2023 S$0.46 B-53.56%
2022 S$0.99 B-3.96%
2021 S$1.03 B-20.26%
2020 S$1.29 B72.88%
2019 S$0.74 B3.11%
2018 S$0.72 B73.54%
2017 S$0.41 B464.88%
2016 S$74.06 M-77.32%
2015 S$0.32 B36.31%
2014 S$0.23 B-10.81%
2013 S$0.26 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.35 B-57,124.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.81 B-47,665.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.16 B-108,373.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.28 B-4,887.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.40 B-38,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.68 B-39,765.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.16 B-727.01%๐Ÿ‡บ๐Ÿ‡ธ USA